Global Albendazole Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: May 24, 2021 |

The global albendazole market size is anticipated to register a significant CAGR of 3.6% over the forecast period from 2021 to 2027 and estimated to reach 781 million by 2027. The significant increase in the soil-transmitted helminths infection worldwide primarily drives the albendazole market growth. Furthermore, effective implementation of treatment guidelines pertaining to parasitic infection by healthcare agencies throughout the globe further accentuates the albendazole market growth.

Albendazole is considered as a broad spectrum anthelmintic drug which exerts its pharmacological activity by inhibiting the tubulin polymerization which eventually causes the loss of cytoplasmic tubulin. This phenomenon causes the depletion of the glycogen stores of the parasites which is critical for its survival. Albendazole is enlisted in the World Health Organization (WHO), list of essential medicines. It needs to be taken under medical supervision as overdose in children might result in fatal outcomes.

Market Segment Insights:

In the present scenario the soil-transmitted helminths infection is dominating the clinical application segment for albendazole market. According to the latest research citings presented by the Center for Disease Control and Prevention (CDC), soil transmitted helminths infection also called as the neglected tropical disease usually occurs in the warm & moist climate where there is poor civic amenities and hygiene. The Ascaris infection is reported in approximately 807-1,121 million people, whipworm is reported in 604-795 million and hookworm is reported in 576-740 million people worldwide. Schistosomiasis is expected to register rampant market growth during the forecast period. Rapid industrialization in developing countries has resulted in tremendous water pollution which provides potent breeding grounds for schistosomiasis pathogens. According to the latest research citings provided by the World Health Organization (WHO), approximately 290.8 million people worldwide received treatment for schistosomiasis in 2018.

Albendazole Market Size & CAGR

To know more about the study, request sample papers

Hospital pharmacy is currently spearheading the distribution channel segment for the albendazole market. Overdose associated with albendazole has fatal effects among the children population suffering from helminthic infections, hence it is mandatory for the hospital pharmacist to precisely compound the albendazole drug formulation in accordance with the physician’s prescription. Retail pharmacy has gained tremendous traction in the last 2 decades in the developing regions owing to the flourishing generic drugs market and ability to provide medicines at affordable prices.

The albendazole market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Albendazole Market Segmentation:

By Clinical Application:

  • Soil-transmitted Helminths
  • Schistosomiasis
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

The Asia Pacific is presently leading the geography segment for the albendazole market. The rising prevalence of soil-transmitted helminths infection primarily drives the albendazole market growth in the region. The tropical climate prevalent in the South East Asian countries provides a teeming growing for the spread of neglected tropical diseases. Domicile of key players in the region such as Cadila Healthcare Limited, Cipla Limited., GlaxoSmithKline, Plc., Dr. Reddys Laboratories Ltd. etc further accentuate the albendazole market growth in the region. Latin America is the second-largest regional segment in the albendazole market. The rising prevalence of schistosomiasis infection in the rainforest region determines the albendazole market growth in the region. North America is anticipated to register the fastest market growth in the regional segment for the albendazole market. The South-Eastern region of the United States shows few cases of helminthic infections, however effective implementation of the treatment guidelines pertaining to parasitic infection drives the demand for albendazole market growth in the North American region.

Market Competition Assessment:

Some of the major players operating in the global albendazole market are Cadila Healthcare Limited., Actavis Pharma, Inc., Cipla Limited, GlaxoSmithKline, Plc., and Mankind Pharma. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Cadila Healthcare Limited
  • Actavis Pharma, Inc.
  • Cipla Limited
  • GlaxoSmithKline, Plc.
  • Genfar S.A.
  • Reddys Laboratories Ltd.
  • Beximco Pharmaceuticals Ltd.
  • Unison Laboratories Co Ltd
  • MEDLEY GENERICOS
  • Mankind Pharma

Key Questions Answered by Albendazole Market Report:

  • Global albendazole market forecasts from 2021-2027
  • Regional albendazole market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Albendazole submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the albendazole market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level albendazole markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the albendazole market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Albendazole Market Portraiture
2.2. Global Albendazole Market, by Clinical Application, 2020 (USD Mn)
2.3. Global Albendazole Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Albendazole Market, by Geography, 2020 (USD Mn)

 

3. Global Albendazole Market Analysis


3.1. Albendazole Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Albendazole Market By Clinical Application, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Soil-transmitted Helminths
4.3. Schistosomiasis
4.4. Others

 

5. Global Albendazole Market By Distribution Channel, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

 

6. North America Albendazole Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Albendazole Market by Clinical Application (2018-2027 USD Mn)
6.1.3. North America Albendazole Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Albendazole Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Albendazole Market by Clinical Application (2018-2027 USD Mn)
6.1.4.1.2. U.S. Albendazole Market by Distribution Channel (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Albendazole Market by Clinical Application (2018-2027 USD Mn)
6.1.4.2.2. Canada Albendazole Market by Distribution Channel (2018-2027 USD Mn)

 

7. Europe Albendazole Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Albendazole Market by Clinical Application (2018-2027 USD Mn)
7.1.3. Europe Albendazole Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Albendazole Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Albendazole Market by Clinical Application (2018-2027 USD Mn)
7.1.4.1.2. Germany Albendazole Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Albendazole Market by Clinical Application (2018-2027 USD Mn)
7.1.4.2.2. U.K. Albendazole Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Albendazole Market by Clinical Application (2018-2027 USD Mn)
7.1.4.3.2. France Albendazole Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Albendazole Market by Clinical Application (2018-2027 USD Mn)
7.1.4.4.2. Italy Albendazole Market by Distribution Channel (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Albendazole Market by Clinical Application (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Albendazole Market by Distribution Channel (2018-2027 USD Mn)

 

8. Asia Pacific Albendazole Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Albendazole Market by Clinical Application (2018-2027 USD Mn)
8.1.3. Asia Pacific Albendazole Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Albendazole Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Albendazole Market by Clinical Application (2018-2027 USD Mn)
8.1.4.1.2. China Albendazole Market by Distribution Channel (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Albendazole Market by Clinical Application (2018-2027 USD Mn)
8.1.4.2.2. Japan Albendazole Market by Distribution Channel (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Albendazole Market by Clinical Application (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Albendazole Market by Distribution Channel (2018-2027 USD Mn)

 

9. Latin America (LATAM) Albendazole Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Albendazole Market by Clinical Application (2018-2027 USD Mn)
9.1.3. Latin America Albendazole Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Albendazole Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Albendazole Market by Clinical Application (2018-2027 USD Mn)
9.1.4.1.2. Brazil Albendazole Market by Distribution Channel (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Albendazole Market by Clinical Application (2018-2027 USD Mn)
9.1.4.2.2. Mexico Albendazole Market by Distribution Channel (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Albendazole Market by Clinical Application (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Albendazole Market by Distribution Channel (2018-2027 USD Mn)

 

10. Middle East and Africa Albendazole Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Albendazole Market by Clinical Application (2018-2027 USD Mn)
10.1.3. MEA Albendazole Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Albendazole Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Albendazole Market by Clinical Application (2018-2027 USD Mn)
10.1.4.1.2. GCC Albendazole Market by Distribution Channel (2018-2027 USD Mn)
10.1.4.2. Rest of MEA
10.1.4.2.1. Rest of MEA Albendazole Market by Clinical Application (2018-2027 USD Mn)
10.1.4.2.2. Rest of MEA Albendazole Market by Distribution Channel (2018-2027 USD Mn)

 

11. Company Profiles


11.1. Cadila Healthcare Limited
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Actavis Pharma, Inc.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Cipla Limited
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. GlaxoSmithKline, Plc.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Genfar S.A.
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Dr. Reddys Laboratories Ltd.
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Beximco Pharmaceuticals Ltd.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Unison Laboratories Co Ltd.
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. MEDLEY GENERICOS
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Mankind Pharma
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Albendazole Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying


Select License Type
$ 3600/- Single User License
$ 4800/- Multi User License
$ 6800/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report

Impacts of COVID-19
COVID-19 Impact on the Albendazole Market


Our Clients